Skip to main content

Table 2 Recurrence after radical resection in the TME and CCRT + TME groups

From: Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial

Variable

TME group [cases (%)]

CCRT + TME group [cases (%)]

P value

Postoperative recurrence

0.971

 Yes

19 (20.2)

18 (20.0)

 

 No

75 (79.8)

72 (80.0)

 

Recurrence period

0.858

 Early recurrence (≤ 24 months)

10 (52.6)

10 (55.6)

 

 Late recurrence (> 24 months)

9 (47.4)

8 (44.4)

 

Recurrence patterna

 Local recurrence

4 (4.3)

5 (5.6)

0.743

 Liver metastasis

2 (2.1)

4 (4.4)

0.437

 Lung metastasis

9 (9.6)

7 (7.8)

0.665

 Other site metastasis

4 (4.3)

6 (6.7)

0.530

  1. TME, total mesorectal excision; CCRT, concurrent chemoradiotherapy
  2. aThere were 3 patients developed multiple metastasis